ioxaglate (Hexabrix) Report issue

Small molecule Approved FDA
ChEMBL Drug Central PubChem

Active Ingredient History

NOW
  • Now
Ioxaglic acid is pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. It has low osmolality, typically resulting in fewer side effects than high-osmolality media. It is manufactured by Guerbet, but marketing in the US has been discontinued. As of 2021, it may still be available in some European countries.   Wikipedia

Chemistry

  • SMILES: CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC(=O)c1c(I)c(N(C)C(=O)C)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c1I
  • InChIKey: HUHDYASLFWQVOL-WZTVWXICSA-N
  • Mol. Mass: 1464.1
  • ALogP: Missing data
  • ChEMBL Molecules:
    ioxaglate meglumine  
    ioxaglate sodium  
More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

hexabrix | ioxaglate meglumine | ioxaglate meglumine; ioxaglate sodium | ioxaglate sodium | mp-302 | mp-302 (mixt. with ioxaglate sodium) | sodium ioxaglate

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue